Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value
$2.86−0.14 (-4.67%)
Close on Nov 13, 2026Market cap $122.83MP/E –Yield –
Pulmonx ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Pulmonx
Pulmonx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?